Institution statistics - TECHNOLOGY TRANSFER

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - France 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 TECHNOLOGY TRANSFER):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 47
As coordinator: 7
As participant: 33
Sole participant: 7
Coordinator / Participant Ratio: 0.21*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 230.747 619.200 536.747 1 1
2010 896.994 609.297 1.035.271 5 1
2009 3.000.000 0 176.471 1
2007 0 6.098.090 644.419 4
2006 0 4.203.990 438.827 3
2005 3.626.000 3.495.688 1.377.029 1 2
2004 0 8.521.536 586.443 4
2003 0 1.400.000 36.842 1
2002 2.223.046 12.757.491 2.378.087 2 7
2001 1.383.839 4.511.290 958.779 1 3
2000 2.628.825 15.833.945 2.823.155 3 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE171
KAROLINSKA INSTITUTE139
UNIVERSITY COLLEGE LONDON120
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD86
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE82
INSERM TRANSFERT76
KATHOLIEKE UNIVERSITEIT LEUVEN73
KING'S COLLEGE LONDON72
CHARITE UNIVERSITAETSMEDIZIN BERLIN65
MEDICAL RESEARCH COUNCIL63
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE58
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM55
STICHTING KATHOLIEKE UNIVERSITEIT52
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS51
UPPSALA UNIVERSITET51
COMMISSARIAT A L'ENERGIE ATOMIQUE50
EUROPEAN MOLECULAR BIOLOGY LABORATORY50
INSTITUT PASTEUR50
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT43
MEDIZINISCHE UNIVERSITAET WIEN42
UNIVERSITY OF COPENHAGEN42
ISTITUTO SUPERIORE DI SANITA40
LEIDEN UNIVERSITY MEDICAL CENTER40
UNIVERSITY OF HELSINKI40
UNIVERSITY OF NEWCASTLE UPON TYNE40
CONSIGLIO NAZIONALE DELLE RICERCHE39
THE UNIVERSITY OF EDINBURGH38
THE UNIVERSITY OF MANCHESTER38
UNIVERSITE DE GENEVE38
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS37
UNIVERSITAETSKLINIKUM HEIDELBERG37
UNIVERSITY OF GLASGOW36
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN35
LUNDS UNIVERSITET35
UNIVERSITAETSKLINIKUM FREIBURG34
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV33
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE32
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR32
UNIVERSITAIR MEDISCH CENTRUM UTRECHT32
ACADEMISCH ZIEKENHUIS GRONINGEN31
EBERHARD KARLS UNIVERSITAET TUEBINGEN31
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM30
MEDIZINISCHE HOCHSCHULE HANNOVER29
UNIVERSITAET ZUERICH29
UNIVERSITA DEGLI STUDI DI MILANO28
UNIVERSITE CATHOLIQUE DE LOUVAIN28
UNIVERSITE LIBRE DE BRUXELLES28
UNIVERSITA DEGLI STUDI DI PADOVA26
UNIVERSITAET ULM26
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH25
UNIVERSITEIT MAASTRICHT25
WEIZMANN INSTITUTE OF SCIENCE25
INSTITUTO DE SALUD CARLOS III24
UNIVERSITE DE LIEGE24
UNIVERSITY OF BIRMINGHAM24
UNIVERSITY OF DUNDEE24
DEUTSCHES KREBSFORSCHUNGSZENTRUM23
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI23
UNIVERSITEIT GENT23
UNIVERSITEIT UTRECHT23
UNIVERSITY OF WALES CARDIFF23
GOETEBORGS UNIVERSITET22
REGION HOVEDSTADEN22
UNIVERSITY OF LEICESTER22
UNIVERSITY OF OSLO22
UNIVERSITY OF SOUTHAMPTON22
ACADEMISCH ZIEKENHUIS LEIDEN21
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI21
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV21
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON21
RUPRECHT KARLS UNIVERSITAET HEIDELBERG21
SERVICIO MADRILENO DE SALUD21
TARTU ULIKOOL21
TECHNISCHE UNIVERSITAET DRESDEN21
THE UNIVERSITY OF LIVERPOOL21
THE UNIVERSITY OF SHEFFIELD21
UNIVERSITA DEGLI STUDI DI TORINO21
UNIVERSITY OF BRISTOL21
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER20
GENOME RESEARCH20
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS20
UNIVERSITY OF BERGEN20
UNIVERSITY OF LEEDS19
HEINRICHHEINEUNIVERSITAET DUESSELDORF18
LEIDEN UNIVERSITY18
TEL AVIV UNIVERSITY18
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA18
UNIVERSITAET BERN18
VRIJE UNIVERSITEIT BRUSSEL18
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS17
PHILIPPS UNIVERSITAET MARBURG17
ST GEORGE'S HOSPITAL MEDICAL SCHOOL17
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS17
UNIVERSITY OF AARHUS17
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM16
ALBERT LUDWIGS UNIVERSITAET FREIBURG16
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V16
KUNGLIGA TEKNISKA HOEGSKOLAN16
NATIONAL UNIVERSITY OF IRELAND GALWAY16
OSPEDALE PEDIATRICO BAMBINO GESU16
Constancy:

Total number of partners:11736

Partner loyalty:
Frequent Partner: (> 2 projects): 7676
Rare Partner: 4060

Frequent / Rare Partner Ratio: 1.89

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES577
RTD HORIZONTAL TOPICS389
SOCIAL AND ECONOMIC CONCERNS222
PROTECTING MAN AND HIS ENVIRON93
INDUSTRY AND TECHNOLOGY60
AGRICULTURE AND MARINE RESOURC21
ENERGY6
MEASUREMENTS AND STANDARDS3
PHYSICAL AND EXACT SCIENCES3

Project overview:

Start dateProjectacronymrolefundingpartners
2011-03-01International Network for Early Childhood Health Development INECHDparticipant619.2002
2011-02-01Impact of IL-7 and IFNa on nTreg development 3ITDcoordinator230.7471
2010-12-13Basal ganglia and the control of locomotion BasalGangliaNetworkscoordinator161.2932
2010-11-01Real-time decoding of conscious and non-conscious perceptual events in the human brain CODECcoordinator174.1621
2010-11-01Role of Ebf3 in the distribution of Cajal-Retzius cells Neuromigrationcoordinator230.2471
2010-09-01Impact of the chromatin environment on the CTG repeat instability involved in myotonic dystrophy type 1 DM and Chromatincoordinator165.1461
2010-07-01METABOLIC EFFECTS OF LEUCINE SUPPLEMENTATION ON THE PREVENTION AND TREATMENT OF DIET-INDUCED OBESITY LeuObesecoordinator166.1461
2010-05-15IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS AS APPLIED TO CHRONIC KIDNEY DISEASE PROTOCLINparticipant609.2973
2009-02-01Signalling in life cycle stages of malaria parasites MALSIGcoordinator3.000.00017
2007-03-01European value of a quality adjusted life year EUROVAQparticipant1.399.17114
2007-01-01Host-Specific variants of the influenza virus replication machinery FLUPOLparticipant1.973.4507
2007-01-01Tackling the social and economic determinants of nutrition and physical activity for the prevention of obesity in Europe EURO-PREVOBparticipant1.664.19715
2007-01-01Health-promotion through obesity prevention across Europe (hope): an integrated analysis to support European health policy HOPEparticipant1.061.2727
2006-09-01Learning and practicing pharmacovigilance in the Mediterranean countries of the EU MED EPHVparticipant804.4209
2006-07-01New tools for genetic engineering using targeted integration vectors application to agronomy food safety and gene therapy INTEGRAparticipant1.999.5709
2006-01-01Cord blood as an allogeneic source of stem cell for clinical use participant1.400.00011
2005-09-01Neocortical Daisy Architectures and Graphical Models for context-dependent Processing DAISYcoordinator3.626.0004
2005-02-01Policy-oriented and harmonising research activities in the field of primary immunodeficiency diseases (PIDs) EURO-POLICY-PIDparticipant1.879.8007
2005-01-01Highly parallel cell culture in nanodrops, a new format for high content cell based toxicity screening on cell on chips TOXDROPparticipant1.615.8888
2004-10-01Workshop on creation of biopharmaceutical development platforms with involvement of biotech SMEs PHARMTECH PLATFORMparticipant224.9806
2004-08-01Control policy optimisation for SARS and other emerging infections: characterising transmission dynamics and estimating key epidemiological parameters SARSTRANSparticipant1.700.0007
2004-04-01Prevention of future SARS epidemics through the control of animal and human infection EPISARSparticipant1.596.55618
2004-01-01Semantic Interoperability and Data Mining in Biomedicine SEMANTICMININGparticipant5.000.00023
2003-03-01Evaluation of the facilitation of umbilical cord blood transplant engraftment using ex vivo haematopoietic progenitor/stem cell expansion. EUROCORD I I Iparticipant1.400.00038
2002-12-01Engineered mesenchymal stem cells combined with gene therapy for osteoarticular disease STEMGENOSparticipant1.729.9407
2002-11-01Synthesis and mechanism of action of novel classes of retinoids and rexinoids with antineoplastic activities ANTICANCER RETINOIDSparticipant1.140.3597
2002-11-01Clearance of apoptotic cells: discovery of autoantigens and therapy for autoimmune diseases APOCLEARparticipant2.056.2059
2002-05-01A bioartificial brain with an artificial body: training a cultured neural tissue to support the purposive behavior of an artificial body NEUROBITparticipant1.673.0007
2002-03-01Quantitative evaluations of cellular interactions with bioactive biofilms KULCSAR AGNEScoordinator125.8001
2002-01-01Biodegradable controlled drug delivery systems for the treatment of brain diseases BCDDScoordinator2.097.2466
2002-01-01Biochemical and functional characterization of antigen presenting cell derived-exosomes: the design of a cell free cancer vaccine EXOSOMEparticipant1.909.0906
2002-01-01Novel therapeutic tools and strategies to fight polycystic kidney disease GTPKDparticipant1.751.2095
2002-01-01Gene therapy of hematopoietic stem cells for inherited diseases INHERINETparticipant2.497.6887
2001-11-01Quality in molecular genetic testing: development of certified reference materials (CRMGEN) CRMGENparticipant1.284.91012
2001-11-01Microelectronic Device for Individual Cell Sorting MEDICSparticipant1.000.0004
2001-09-01Development and clinical study of a bioartificial liver based on reversibly immortalised human hepatocytes BIOARTIFICIAL LIVERparticipant2.226.3806
2001-03-01New systems of controlled gene expression for improved delivery of therapeutic substances CONTEXTHcoordinator1.383.8396
2000-12-01Disease insights from single cell signaling MOLECULAR SIGNALINGparticipant907.3126
2000-11-20Isoforms and polymorphisms of the histamine h3 receptor : pharmacological and therapeutic implications ASTRID SASSEcoordinator125.5501
2000-03-01European cell therapy in the nervous system ECTINSparticipant4.217.9769
2000-03-01Preclinical evaluation of delivery systems for neuroprotective gene therapy in neurodegenerative diseases. NEUROGETcoordinator1.225.2827
2000-02-01Biomechanical interactions in tissue engineering and surgical repair BITESparticipant2.104.9999
2000-02-01Development of high-throughput pna-based molecular diagnostic systems EUPNAcoordinator1.277.9936
2000-02-01Molecular evolution of protease substrates involved in carcinogenesis by in vivo selection of retroviral display libraries PROTEASE SUBSTRATESparticipant2.032.9394
2000-02-01Targeted vectors for cancer gene therapy: receptor and tran-scriptional targeting of retroviral, lentiviral, and adenoviral vectors TARGETED GENE VECTORparticipant2.099.8206
2000-02-01Lentiviral vectors for gene therapy of the hematopoietic system: development from bench to bedside LENTIVIRAL VECTORSparticipant2.826.6566
2000-01-01Thematic network around cystic fibrosis and releated diseases participant1.644.24313

Alias institution names:
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE UNITE DE RECHERCHE 515 HOPITAL SAINTANTOINE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum